Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CELESTICA INC insiders sold a net $152.4M of stock across 198 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Feb 4, 2026.
The trade is 27.5% of the 73,252 shares held after it.
1 other insider sold within 30 days.
520 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President Cooper Todd C sold about $7.2M of CLS under a 10b5-1 plan on Sep 23, 2026; 1 other insider sold within 30 days and 520 funds added in the latest 13F quarter.
109 earlier Form 4 trades (code P or S) here by this insider (109 sales), the last on Aug 13, 2026.
The trade is 8.9% of the 21,476 shares held after it.
1 other insider sold within 30 days.
520 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MIONIS ROBERT sold about $691.9K of CLS under a 10b5-1 plan on Sep 23, 2026; 1 other insider sold within 30 days and 520 funds added in the latest 13F quarter.
109 earlier Form 4 trades (code P or S) here by this insider (109 sales), the last on Aug 13, 2026.
The trade is 12.0% of the 19,182 shares held after it.
1 other insider sold within 30 days.
520 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MIONIS ROBERT sold about $828.6K of CLS under a 10b5-1 plan on Sep 23, 2026; 1 other insider sold within 30 days and 520 funds added in the latest 13F quarter.
109 earlier Form 4 trades (code P or S) here by this insider (109 sales), the last on Aug 13, 2026.
The trade is 14.8% of the 16,702 shares held after it.
1 other insider sold within 30 days.
520 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MIONIS ROBERT sold about $899.0K of CLS under a 10b5-1 plan on Sep 23, 2026; 1 other insider sold within 30 days and 520 funds added in the latest 13F quarter.
109 earlier Form 4 trades (code P or S) here by this insider (109 sales), the last on Aug 13, 2026.
The trade is 18.4% of the 14,112 shares held after it.
1 other insider sold within 30 days.
520 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MIONIS ROBERT sold about $941.4K of CLS under a 10b5-1 plan on Sep 23, 2026; 1 other insider sold within 30 days and 520 funds added in the latest 13F quarter.
198 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CLS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Cooper Todd C
Filed 2026-09-23
$7.2M
CHAWLA MANDEEP
Filed 2026-07-31
$6.0M
MIONIS ROBERT
Filed 2026-07-31
$74.1M
CLS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Siren NexGen Economy ETF
$1.8M position · as of 2026-06-30
4.8%
Franklin Intelligent Machines ETF
$5.0M position · as of 2026-06-30
4.3%
One Rock Fund
$2.1M position · as of 2026-05-31
3.6%
Chase Growth Fund
$4.1M position · as of 2026-06-30
3.1%
Aztlan North America Nearshoring Stock Selection ETF
$917.9K position · as of 2026-07-31
3.1%
Bancreek International Large Cap ETF
$2.9M position · as of 2026-05-31
3.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Robert A. Mionis
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$17.4M
$320.8M
$4.0M
+2556%
+60%
2024
$15.0M
$138.9M
$3.7M
+729%
+37%
2023
$13.5M
$66.3M
$3.5M
+163%
+6%
2022
$12.0M
$17.5M
$3.4M
+1%
-25%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $152.4M sold by insiders over 180 days, 520 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $87.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt CLS
FY Dec 2025
0.88x
FY Dec 2024
0.62x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
1.46x
Mar 2026
1.19x
Dec 2025
0.88x
Sep 2025
0.73x
Jun 2025
0.65x
Mar 2025
0.54x
Dec 2024
0.62x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+52.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CLS
FY Dec 2025
+40.5%
FY Dec 2024
+23.3%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+52.7%
Mar 2026
+52.5%
Dec 2025
+40.5%
Sep 2025
+37.3%
Jun 2025
+30.3%
Mar 2025
+25.9%
Dec 2024
+23.3%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+13.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CLS
FY Dec 2025
+12.6%
FY Dec 2024
+7.2%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+13.9%
Mar 2026
+13.6%
Dec 2025
+12.6%
Sep 2025
+10.8%
Jun 2025
+8.6%
Mar 2025
+7.2%
Dec 2024
+7.2%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+47.1%
operating income after a 14.8% effective tax rate, over long-term debt only, 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CLS
FY Dec 2025
+38.4%
FY Dec 2024
+21.8%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+47.1%
Mar 2026
+45.1%
Dec 2025
+38.4%
Sep 2025
+32.2%
Jun 2025
+25.2%
Mar 2025
+21.0%
Dec 2024
+21.8%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+42.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CLS
FY Dec 2025
+33.4%
FY Dec 2024
+21.3%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+42.0%
Mar 2026
+39.7%
Dec 2025
+33.4%
Sep 2025
+29.9%
Jun 2025
+25.4%
Mar 2025
+21.7%
Dec 2024
+21.3%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
27.06x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CLS
FY Dec 2025
41.23x
FY Dec 2024
25.57x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
37.96x
Mar 2026
34.10x
Dec 2025
41.23x
Sep 2025
40.00x
Jun 2025
33.94x
Mar 2025
22.01x
Dec 2024
25.57x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$30.1B
market value at close 2026-10-23 on 2026-07-22 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value CLS
FY Dec 2025
$34.2B
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$42.2B
Mar 2026
$32.8B
Dec 2025
$34.2B
Sep 2025
$28.8B
Jun 2025
$18.5B
Mar 2025
$9.8B
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+1.7%
TTM free cash flow over market value at close 2026-10-23
FCF yield CLS
FY Dec 2025
+1.3%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+1.2%
Mar 2026
+1.5%
Dec 2025
+1.3%
Sep 2025
+1.4%
Jun 2025
+2.2%
Mar 2025
+3.6%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.25x
P/E over trailing EPS growth of 109%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CLS
FY Dec 2025
0.42x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.35x
Mar 2026
0.26x
Dec 2025
0.42x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CLS ranks highest on profitability (93rd percentile) and growth (72nd), and lowest on insider conviction (5th), among Semiconductors & Electronics peers.
Profitability
93
Inputs
Return on equity+52.7% · 96 pct, sector of 154
Return on assets+13.9% · 88 pct, sector of 171
Return on invested capital+47.1% · 89 pct, sector of 56
Return on capital employed+42.0% · 97 pct, sector of 155
Financial health
64
Inputs
Debt to equity0.32x · 44 pct, sector of 152
Cash flow to debt1.46x · 84 pct, sector of 136
Growth
72
Inputs
Revenue growth, YoY+28.5% · 72 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
5
Inputs
Net Form 4 buying (codes P and S), 180d-$136.6M · 11 pct, sector of 147
Insider buyers, 180d0 · 0 pct, sector of 151
Institutional and government
72
Inputs
Funds adding, latest quarter520 · 86 pct, sector of 184
Congress net buyers, 365d1 · 59 pct, sector of 40
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
48
Inputs
Short interest, % of float+3.9% · 61 pct, sector of 221
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+15.5% · 34 pct, sector of 152
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CLS filings, in plain words
Are Celestica insiders buying or selling CLS?
In the 180 days to 2026-10-27, Celestica insiders were net sellers, a net $152.4M across purchases and sales reported on Form 4, by 4 sellers.
Have members of Congress traded CLS?
Yes. In the year to 2026-10-27, 1 House member disclosed buying CLS and 0 House members disclosed selling it; the latest on record is a purchase by Cleo Fields dated 2025-11-03.
Are there planned insider sales of CLS?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $87.4M of stock; the latest, by Cooper Todd C, was filed 2026-09-23.
Read the full summary
In the 180 days to 2026-10-27, Celestica insiders were net sellers of CLS, a net $152.4M across purchases and sales reported on Form 4 by 4 sellers. 6% of the 150 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 1 member of Congress disclosed buying CLS and 0 members disclosed selling it; the latest on record is a purchase by Cleo Fields dated 2025-11-03. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $87.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.